FDA approves Journey Medical's drug for long-term skin condition

Fortress Biotech

04/11/2024 12:09

Nov 4 (Reuters) - The U.S. Food and Drug Administration
has approved Journey Medical's  DERM.O  drug for the treatment
of a long-term skin condition called rosacea, the company said
on Monday.
    

 (Reporting by Sruthi Narasimha Chari, Puyaan Singh and Mariam
Sunny in Bengaluru; editing by Alan Barona and Shilpi Majumdar)
 ((mailto:SruthiNarasimha.Chari@thomsonreuters.com;
mailto:puyaan.singh@thomsonreuters.com))